Raras
Buscar doenças, sintomas, genes...
Displasia epifisária múltipla, tipo Beighton

Displasia epifisária múltipla, tipo Beighton, é uma displasia esquelética (uma alteração no desenvolvimento dos ossos) caracterizada por um desenvolvimento anormal das extremidades dos ossos (as epífises), geralmente leve. A condição também está associada a miopia progressiva, afinamento da retina, cataratas com bordas recortadas, surdez condutiva e dedos curtos e grossos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Displasia epifisária múltipla, tipo Beighton, é uma displasia esquelética (uma alteração no desenvolvimento dos ossos) caracterizada por um desenvolvimento anormal das extremidades dos ossos (as epífises), geralmente leve. A condição também está associada a miopia progressiva, afinamento da retina, cataratas com bordas recortadas, surdez condutiva e dedos curtos e grossos.

Publicações científicas
458 artigos
Último publicado: 2026
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
4 sintomas
👁️
Olhos
3 sintomas
😀
Face
2 sintomas
👂
Ouvidos
1 sintomas

+ 5 sintomas em outras categorias

Características mais comuns

Miopia
Catarata
Braquidactilia
Face redonda
Boca estreita
Baixa estatura
15sintomas
Sem dados (15)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 15 características clínicas mais associadas, ordenadas por frequência.

MiopiaMyopia
CatarataCataract
BraquidactiliaBrachydactyly
Face redondaRound face
Boca estreitaNarrow mouth

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa10
Total histórico458PubMed
Últimos 10 anos9publicações
Pico20192 papers
Linha do tempo
20202016Hoje · 2026📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

COL2A1Collagen alpha-1(II) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Type II collagen is specific for cartilaginous tissues. It is essential for the normal embryonic development of the skeleton, for linear growth and for the ability of cartilage to resist compressive forces

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (10)
Integrin cell surface interactionsMET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresSignaling by PDGF
MECANISMO DE DOENÇA

Spondyloepiphyseal dysplasia congenital type

Disorder characterized by disproportionate short stature and pleiotropic involvement of the skeletal and ocular systems.

OUTRAS DOENÇAS (22)
Legg-Calve-Perthes diseasespondylometaphyseal dysplasia, Schmidt typeplatyspondylic dysplasia, Torrance typeKniest dysplasia
HGNC:2200UniProt:P02458

Variantes genéticas (ClinVar)

1,449 variantes patogênicas registradas no ClinVar.

🧬 COL2A1: NM_001844.5(COL2A1):c.2957C>T (p.Pro986Leu) ()
🧬 COL2A1: NM_001844.5(COL2A1):c.2464-2A>T ()
🧬 COL2A1: NM_001844.5(COL2A1):c.3635G>T (p.Gly1212Val) ()
🧬 COL2A1: NM_001844.5(COL2A1):c.3166-1G>C ()
🧬 COL2A1: NM_001844.5(COL2A1):c.944G>C (p.Gly315Ala) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 59 variantes classificadas pelo ClinVar.

44
12
3
Patogênica (74.6%)
VUS (20.3%)
Benigna (5.1%)
VARIANTES MAIS SIGNIFICATIVAS
COL2A1: NM_001844.5(COL2A1):c.2957C>T (p.Pro986Leu) [Likely pathogenic]
COL2A1: NM_001844.5(COL2A1):c.2464-2A>T [Likely pathogenic]
COL2A1: NM_001844.5(COL2A1):c.2923G>A (p.Gly975Ser) [Likely pathogenic]
COL2A1: NM_001844.5(COL2A1):c.917_918delinsA (p.Gly306fs) [Likely pathogenic]
COL2A1: NM_001844.5(COL2A1):c.1365+3A>C [Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Displasia epifisária múltipla, tipo Beighton

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Echocardiographic abnormalities and joint hypermobility in Chinese patients with Osteogenesis imperfecta.

Orphanet journal of rare diseases2024 Mar 12

Very little is known about the characteristics of echocardiographic abnormalities and joint hypermobility in Chinese patients with osteogenesis imperfecta (OI). The aim of our study was to investigate the characteristics, prevalence and correlation of echocardiographic abnormalities and joint hypermobility in Chinese patients with OI. A cross-sectional comparative study was conducted in pediatric and adult OI patients who were matched in age and sex with healthy controls. Transthoracic echocardiography was performed in all patients and controls, and parameters were indexed for body surface area (BSA). The Beighton score was used to evaluate the degree of joint hypermobility. A total of 48 patients with OI (25 juveniles and 23 adults) and 129 age- and sex-matched healthy controls (79 juveniles and 50 adults) were studied. Four genes (COL1A1, COL1A2, IFITM5, and WNT1) and 39 different mutation loci were identified in our study. Mild valvular regurgitation was the most common cardiac abnormality: mild mitral and tricuspid regurgitation was found in 12% and 36% of pediatric OI patients, respectively; among 23 OI adults, 13% and 17% of patients had mild mitral and tricuspid regurgitation, respectively, and 4% had mild aortic regurgitation. In multiple regression analysis, OI was the key predictor of left atrium diameter (LAD) (β=-3.670, P < 0.001) and fractional shortening (FS) (β = 3.005, P = 0.037) in juveniles, whereas for adults, OI was a significant predictor of LAD (β=-3.621, P < 0.001) and left ventricular mass (LVM) (β = 58.928, P < 0.001). The percentages of generalized joint hypermobility in OI juveniles and adults were 56% and 20%, respectively. Additionally, only in the OI juvenile group did the results of the Mann‒Whitney U test show that the degree of joint hypermobility was significantly different between the echocardiographic normal and abnormal groups (P = 0.004). Mild valvular regurgitation was the most common cardiac abnormality in both OI juveniles and adults. Compared with OI adults, OI juveniles had more prevalent and wider joint hypermobility. Echocardiographic abnormalities may imply that the impairment of type I collagen is more serious in OI. Baseline echocardiography should be performed in OI patients as early as possible.

#2

Kazimierz S. Kozlowski, 1928.

Seminars in musculoskeletal radiology2023 Apr

This history page in the series "Leaders in MSK Radiology" is dedicated to the achievements of the Polish radiologist Kazimierz Kozlowski, whose name is associated with the Kozlowski type of spondylometaphyseal dysplasia.

#3

The evolution of the nosology of osteogenesis imperfecta.

Clinical genetics2021 Jan

Osteogenesis imperfecta (OI) is a relatively common genetic skeletal disorder with an estimated frequency of 1 in 20 000 worldwide. The manifestations are diverse and although individually rare, the several different forms contribute to the production of a significant number of affected individuals with considerable morbidity and mortality. During the last decade, there have been extensive molecular investigations into the etiology of OI and these advances have direct relevance to the medical management of the disorder, and the purpose of this review is to document the history and evolution of the nosology of OI. The current nosology, based on molecular concepts, which are crucial in the identification of genotype-phenotype correlations in persons with OI, is also outlined. The successive revisions of the nosology and classification of OI have highlighted the importance of the nomenclature of the condition in order for it to be recognized by clinicians, scientists and patient advocacy groups. In this way, improved counseling of patients and individualized, tailored therapeutic approaches based on the underlying pathophysiology of the individual's type of OI have been facilitated.

#4

Broadening the phenotypic spectrum of Beta3GalT6-associated phenotypes.

American journal of medical genetics. Part A2021 Oct

Biallelic mutations in B3GALT6, coding for a galactosyltransferase involved in the synthesis of glycosaminoglycans (GAGs), have been associated with various clinical conditions, causing spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMDJL1 or SEMDJL Beighton type), Al-Gazali syndrome (ALGAZ), and a severe progeroid form of Ehlers-Danlos syndrome (EDSSPD2). In the 2017 Ehlers-Danlos syndrome (EDS) classification, Beta3GalT6-related disorders were grouped in the spondylodysplastic EDSs together with spondylodysplastic EDSs due to B4GALT7 and SLC39A13 mutations. Herein, we describe a patient with a previously unreported homozygous pathogenic B3GALT6 variant resulting in a complex phenotype more severe than spondyloepimetaphyseal dysplasia with joint laxity type 1, and having dural ectasia and aortic dilation as additionally associated features, further broadening the phenotypic spectrum of the Beta3GalT6-related syndromes. We also document the utility of repeating sequencing in patients with uninformative exomes, particularly when performed by using "first generations" enrichment capture methods.

#5

Namaqualand hip dysplasia in South Africa: The molecular determinant elucidated.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde2020 Dec 14

Namaqualand hip dysplasia (NHD) is a mild form of spondyloepiphyseal dysplasia in which progressive arthropathy of the hip joint is a major manifestation. The disorder was documented in a multigenerational South African (SA) family with antecedents from Namaqualand, a region in the north-west of the country. Linkage analysis revealed a locus that includes the collagen type II gene, COL2A1. To identify the pathogenic COL2A1 variant causing NHD in an SA family. One affected male with a clear diagnosis of NHD was selected for whole-exome sequencing (WES) on the Ion Torrent Proton platform. A probe-based assay and direct cycle sequencing were used to confirm that the prioritised variant segregated with the phenotype in the NHD family and was not present in unrelated controls from the same population. WES identified one heterozygous variant, c.2014G&gt;T; p.(Gly672Cys), in the coding sequence of the COL2A1 gene. The variant segregated with NHD in 23 affected family members and was previously reported in a Caucasian male with Perthes disease-like presentation. It is now possible to provide a molecular diagnosis of NHD before hip problems present. The large, clinically well-characterised NHD family is a valuable resource that could provide more insight into the mechanisms responsible for the variable expression observed in individuals with this variant.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Displasia epifisária múltipla, tipo Beighton.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Displasia epifisária múltipla, tipo Beighton

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Echocardiographic abnormalities and joint hypermobility in Chinese patients with Osteogenesis imperfecta.
    Orphanet journal of rare diseases· 2024· PMID 38475860mais citado
  2. Kazimierz S. Kozlowski, 1928.
    Seminars in musculoskeletal radiology· 2023· PMID 37011624mais citado
  3. The evolution of the nosology of osteogenesis imperfecta.
    Clinical genetics· 2021· PMID 32901963mais citado
  4. Broadening the phenotypic spectrum of Beta3GalT6-associated phenotypes.
    American journal of medical genetics. Part A· 2021· PMID 34159694mais citado
  5. Namaqualand hip dysplasia in South Africa: The molecular determinant elucidated.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde· 2020· PMID 33404007mais citado
  6. Genotype-phenotype correlations in PSACH/EDM1 patients with COMP gene variants: a comprehensive review of 830 cases.
    Front Endocrinol (Lausanne)· 2026· PMID 41798190recente
  7. Human pluripotent stem cell model of multiple epiphyseal dysplasia with MATN3 mutation identifies altered matrix organisation and upregulation of the cholesterol biosynthesis pathway.
    Osteoarthritis Cartilage· 2026· PMID 41651153recente
  8. Elevated MMP9 Expression-A Potential In Vitro Biomarker for COMPopathies.
    Int J Mol Sci· 2025· PMID 41465495recente
  9. Exome Sequencing Identifies a Novel Splicing Variant in COL9A3 Resulting in Multiple Epiphyseal Dysplasia: A Case Report.
    Mol Genet Genomic Med· 2025· PMID 41194747recente
  10. From Protein Misfolding to Extracellular Matrix Disorganisation: Understanding Disease Pathology in Rare Skeletal Dysplasias.
    Int J Mol Sci· 2025· PMID 41155349recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:166011(Orphanet)
  2. OMIM OMIM:132450(OMIM)
  3. MONDO:0007562(MONDO)
  4. GARD:17012(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55780563(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Displasia epifisária múltipla, tipo Beighton
Compêndio · Raras BR

Displasia epifisária múltipla, tipo Beighton

ORPHA:166011 · MONDO:0007562
MedGen
UMLS
C1851536
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades